Skip to content

CAR T Cell Study Reveals Intricate Membrane Architecture for Improved Cancer Therapies

New insights into CAR T cell biology could boost cancer therapies. Study reveals dynamic membrane changes during tumor engagement.

In this picture I can see few cars, at the bottom there is the board with the text on it.
In this picture I can see few cars, at the bottom there is the board with the text on it.

CAR T Cell Study Reveals Intricate Membrane Architecture for Improved Cancer Therapies

Scientists have delved into the membrane architecture of CD19-targeting CAR T cells using the Proximity Network Assay, revealing intricate details about these cancer-fighting immune cells. This research, conducted at the University of Cologne Clinic, sheds light on how CAR T cells interact with tumor cells and could pave the way for improved cancer therapies.

CAR T cells, known for their precision in targeting and destroying cancer cells, have been studied in their resting state and during tumor engagement. The Proximity Network Assay showed significant colocalization of the CAR molecule with canonical signaling and adhesion proteins, indicating its integration into functional membrane domains. This integration influences T-cell signaling and activation, impacting CAR T cell persistence and therapeutic efficacy.

The assay also provided quantitative and spatially resolved insights into surface receptor landscapes, capturing multiprotein domains, receptor clustering, and trogocytosis events. Trogocytosis, the acquisition of membrane fragments from tumor cells, was found to induce membrane remodeling and shape CAR T-cell phenotype and efficacy over time. Notably, CAR T cells dynamically reconfigure their surface proteome during antigen engagement, with pronounced alterations in protein profiles observed at four and 24 hours.

Despite the progress in CAR T cell therapy, challenges such as antigen loss and limited success in solid tumors persist. A deeper understanding of CAR T cell biology, facilitated by techniques like the Proximity Network Assay, is crucial for overcoming these hurdles and improving cancer treatment.

The Proximity Network Assay has offered valuable insights into the membrane architecture of CD19-targeting CAR T cells, highlighting the dynamic nature of these cells during tumor engagement. As CAR T cell therapy continues to advance, particularly for hematologic cancers, further research into CAR T cell biology could lead to more effective and durable cancer treatments.

Read also:

Latest